Minimum 10-Year Survivorship of Uncemented Acetabular Reconstruction With Bulk Femoral Head Autografting in Crowe Type IV Developmental Hip Dysplasia
The Journal of Arthroplasty · 2024-10 · 39 (10) · 2542-2546
DOI: 10.1016/j.arth.2024.05.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Arthroplasty, 2024-10. Verfasst von Masahiro Suzuki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Eniwa Hospital, Eniwa, Hokkaido, Japan; Department of Orthopedic Surgery, Fukuoka University Faculty of Medicine, F…. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Acetabulum, Bone Transplantation, Femur Head. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: In total hip arthroplasty (THA) for severe dislocations such as Crowe type IV developmental dysplasia of the hip (DDH), sufficient bone volume for stable fixation of the acetabular component can be achieved by placing a reinforcing bone graft prepared from the resected femoral head into the deficient acetabulum. The purpose of the current study was to examine the long-term survivorship of uncemented THA in conjunction with a bulk femoral head autograft in patients who have Crowe type IV DDH. METHODS: A total of 35 patients (42 hips) who have Crowe type IV DDH and underwent THA using uncemented cup fixation with bulk femoral head autografting were followed up for a mean period of 15.0 years (range, 10.0 to 20.0) postoperatively. Anteroposterior pelvic radiographs were used for measurements such as the horizontal coverage of the grafted bone and the center-edge angle. Kaplan-Meier survivorship analyses were performed with revision of the acetabular component as the endpoint. RESULTS: The Kaplan-Meier analysis indicated 15-year survival rates of 90.4%. The mean horizontal coverage of grafted bone was 46.1% (range, 23.7 to 66.0), and there were 16 cases with horizontal coverage of ≥ 50%. There was no difference in the appearance of a thin (< 1 mm) radiolucency line around the cup between cases with < 50% versus ≥ 50% of the horizontal coverage of grafted bone (4 versus 2 hips; P = .446). Trabecular bridging and remodeling were seen in all cases after mean periods of 4.1 and 9.0 months postoperatively, respectively. Trabecular reorientation was seen in 41 of 42 hips (97.6%) at a mean follow-up of 19.9 months. CONCLUSIONS: Acetabular reconstruction with femoral bulk bone grafting for Crowe type IV DDH resulted in high survival rates and was a good method to restore bone stock and obtain long-term fixation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Eniwa Hospital, Eniwa, Hokkaido, Japan; Department of Orthopedic Surgery, Fukuoka University Faculty of Medicine, Fukuoka, Japan.
- Department of Orthopedic Surgery, Eniwa Hospital, Eniwa, Hokkaido, Japan.
- Department of Orthopedic Surgery, Fukuoka University Faculty of Medicine, Fukuoka, Japan.
Zitieren
APA
Suzuki, M., Masuda, T., Kanno, T., Inoue, M., Abe, S., & Yamamoto, T. (2024). Minimum 10-Year Survivorship of Uncemented Acetabular Reconstruction With Bulk Femoral Head Autografting in Crowe Type IV Developmental Hip Dysplasia. The Journal of Arthroplasty, 39(10), 2542-2546. https://doi.org/10.1016/j.arth.2024.05.013
Vancouver
Suzuki M, Masuda T, Kanno T, Inoue M, Abe S, Yamamoto T. Minimum 10-Year Survivorship of Uncemented Acetabular Reconstruction With Bulk Femoral Head Autografting in Crowe Type IV Developmental Hip Dysplasia. The Journal of Arthroplasty. 2024;39(10):2542-2546. doi:10.1016/j.arth.2024.05.013
BibTeX
@article{Suzuki2024,
author = {Suzuki, Masahiro and Masuda, Takeshi and Kanno, Taiki and Inoue, Masahiro and Abe, Satomi and Yamamoto, Takuaki},
title = {Minimum 10-Year Survivorship of Uncemented Acetabular Reconstruction With Bulk Femoral Head Autografting in Crowe Type IV Developmental Hip Dysplasia},
journal = {The Journal of Arthroplasty},
year = {2024},
volume = {39},
number = {10},
pages = {2542--2546},
doi = {10.1016/j.arth.2024.05.013}
}
EUVIMED